chr1-74201392-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003838.5(FPGT):āc.325A>Gā(p.Ile109Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,607,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003838.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FPGT | NM_003838.5 | c.325A>G | p.Ile109Val | missense_variant | 3/4 | ENST00000370898.9 | NP_003829.4 | |
FPGT-TNNI3K | NM_001112808.3 | c.325A>G | p.Ile109Val | missense_variant | 3/27 | NP_001106279.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FPGT | ENST00000370898.9 | c.325A>G | p.Ile109Val | missense_variant | 3/4 | 1 | NM_003838.5 | ENSP00000359935 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000325 AC: 8AN: 246240Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133456
GnomAD4 exome AF: 0.0000227 AC: 33AN: 1455386Hom.: 0 Cov.: 28 AF XY: 0.0000359 AC XY: 26AN XY: 724360
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.325A>G (p.I109V) alteration is located in exon 3 (coding exon 3) of the FPGT gene. This alteration results from a A to G substitution at nucleotide position 325, causing the isoleucine (I) at amino acid position 109 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at